Skip Navigation
Menu
Original Research |1 May 1958

SCREENING FOR CARDIOVASCULAR DISEASE IN BALTIMORE1

CHARLES M. WYLIE, M.D., Dr.P.H.

FULL TEXT

Abstract

In the last 20 years medical and public health authorities have recognized cardiovascular disease as an increasing problem, the control of which requires both organized community and individual action.

Ten million persons in the United States are estimated to have cardiovascular disease, which causes one out of every two deaths.1 Patients with these long-term diseases lose many workdays and have much permanent disability. These facts increase the importance of cardiovascular disease as a community problem.

Statistics for this group of diseases are based on the incidence and prevalence of diagnosed cases. However, some apparently well persons can have early cardiovascular

FULL TEXT
PDF
Not Available
Citations
Citation

WYLIE CM. SCREENING FOR CARDIOVASCULAR DISEASE IN BALTIMORE1. Ann Intern Med. ;48:1070–1077. doi: 10.7326/0003-4819-48-5-1070

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 1958;48(5):1070-1077.

DOI: 10.7326/0003-4819-48-5-1070

1 Citations

Related Articles
Statins and Multiple Noncardiovascular Outcomes: Umbrella Review of Meta-analyses of Observational Studies and Randomized Controlled Trials
Annals of Internal Medicine; 169 (8): 543-553
Review: Folic acid may reduce risk for CVD and stroke, and B-vitamin complex may reduce risk for stroke
Annals of Internal Medicine; 169 (8): JC44
Clonal Hematopoiesis Confers Predisposition to Both Cardiovascular Disease and Cancer: A Newly Recognized Link Between Two Major Killers
Annals of Internal Medicine; 169 (2): 116-117
Clinical Implications of Revised Pooled Cohort Equations for Estimating Atherosclerotic Cardiovascular Disease Risk
Annals of Internal Medicine; 169 (1): 20-29
View MoreView Less

Journal Club
Review: Folic acid may reduce risk for CVD and stroke, and B-vitamin complex may reduce risk for stroke
Annals of Internal Medicine; 169 (8): JC44
In type 2 diabetes with CVD and kidney disease, empagliflozin reduced mortality and hospitalization
Annals of Internal Medicine; 168 (10): JC52
In stable CVD, rivaroxaban plus aspirin reduced CV events and increased bleeding compared with aspirin alone
Annals of Internal Medicine; 167 (10): JC52
Evolocumab reduced CV events in patients with atherosclerotic CV disease taking high- or moderate-intensity statins
Annals of Internal Medicine; 167 (2): JC7
View MoreView Less

Related Topics
Cardiology

Cardiology.

PubMed Articles
The role of intestinal microbiota in cardiovascular disease.
J Cell Mol Med 2019.
Ideal Cardiovascular Health Metrics and the Risk of Nonalcoholic Fatty Liver Disease: a Cross-sectional Study in Northern China.
Liver Int 2019.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×